MX2019010935A - Panel de marcadores geneticos para el diagnostico de cancer colorrectal. - Google Patents

Panel de marcadores geneticos para el diagnostico de cancer colorrectal.

Info

Publication number
MX2019010935A
MX2019010935A MX2019010935A MX2019010935A MX2019010935A MX 2019010935 A MX2019010935 A MX 2019010935A MX 2019010935 A MX2019010935 A MX 2019010935A MX 2019010935 A MX2019010935 A MX 2019010935A MX 2019010935 A MX2019010935 A MX 2019010935A
Authority
MX
Mexico
Prior art keywords
onset
colorectal cancer
screening
gene marker
marker panel
Prior art date
Application number
MX2019010935A
Other languages
English (en)
Inventor
Molloy Peter
Lapointe Lawrence
PADERSEN Susanne
Original Assignee
Clinical Genomics Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clinical Genomics Pty Ltd filed Critical Clinical Genomics Pty Ltd
Publication of MX2019010935A publication Critical patent/MX2019010935A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Abstract

La presente invención se refiere en términos generales a un método de tamizaje para el inicio, predisposición al inicio y/o avance de neoplasia. De manera más particular, la presente invención se refiere a un método de tamizaje para el inicio, predisposición al inicio y/o avance de neoplasia mediante tamizaje respecto a cambios en los niveles de metilación de un panel de marcadores genéticos incluyendo BCAT1, IKZF1, IRF4, GRASP y/o CAHM. El método de la presente invención es útil en una gama de aplicaciones incluyendo, pero sin limitarse a, aquellas relacionadas con la diagnosis y/o monitoreo de neoplasias colorrectales, tal como adenocarcinosis colorrectal.
MX2019010935A 2012-05-11 2014-11-10 Panel de marcadores geneticos para el diagnostico de cancer colorrectal. MX2019010935A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261646174P 2012-05-11 2012-05-11

Publications (1)

Publication Number Publication Date
MX2019010935A true MX2019010935A (es) 2019-10-24

Family

ID=49549996

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2014013684A MX368034B (es) 2012-05-11 2013-05-10 Panel de marcadores genéticos para el diagnóstico de cáncer colorrectal.
MX2019010935A MX2019010935A (es) 2012-05-11 2014-11-10 Panel de marcadores geneticos para el diagnostico de cancer colorrectal.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2014013684A MX368034B (es) 2012-05-11 2013-05-10 Panel de marcadores genéticos para el diagnóstico de cáncer colorrectal.

Country Status (15)

Country Link
US (2) US11254985B2 (es)
EP (3) EP2847355B1 (es)
JP (3) JP6742726B2 (es)
CN (1) CN104411835B (es)
AU (3) AU2013258880B2 (es)
BR (1) BR112014028122B1 (es)
CA (3) CA2872867C (es)
DK (2) DK3594366T3 (es)
ES (1) ES2749514T3 (es)
HK (1) HK1208058A1 (es)
IL (1) IL235411A0 (es)
MX (2) MX368034B (es)
NZ (1) NZ701527A (es)
WO (1) WO2013166558A1 (es)
ZA (1) ZA201408120B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6085603B2 (ja) * 2011-08-25 2017-02-22 クリニカル ゲノミクス プロプライエタリー リミテッド 結腸直腸がん及び乳がん診断法におけるｄｎａメチル化
NZ701527A (en) * 2012-05-11 2016-07-29 Clinical Genomics Pty Ltd Diagnostic gene marker panel for colorectal cancer
WO2015187823A2 (en) * 2014-06-04 2015-12-10 Quest Diagnostics Investments Incorporated Methylated markers for colorectal cancer
SG11201610113YA (en) * 2014-06-05 2017-01-27 Clinical Genomics Pty Ltd Method for methylation analysis
WO2016201365A2 (en) * 2015-06-12 2016-12-15 Visani Giuseppe Methods for treating cancers
GB201612815D0 (en) * 2016-07-25 2016-09-07 Belgian Volition Sa Novel combination test
CN110770354B (zh) 2017-04-19 2024-03-19 鹍远基因公司 用于文库构建和序列分析的组合物和方法
CN109371138B (zh) * 2018-12-29 2022-10-25 上海奕谱生物科技有限公司 基于甲基化修饰的肿瘤标记物stamp-ep4
AU2019200359A1 (en) * 2019-01-18 2020-09-10 Clinical Genomics Pty Ltd Screening method
KR20220156899A (ko) * 2020-03-20 2022-11-28 싱글레라 헬스 테크놀로지스 (상하이) 엘티디. 결장직장 신생물의 스크리닝을 위한 방법 및 키트
CN115927607A (zh) * 2021-08-17 2023-04-07 武汉艾米森生命科技有限公司 生物标志物在胃癌诊断中的应用

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883750A (en) 1984-12-13 1989-11-28 Applied Biosystems, Inc. Detection of specific sequences in nucleic acids
CA1323293C (en) 1987-12-11 1993-10-19 Keith C. Backman Assay using template-dependent nucleic acid probe reorganization
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
JPH02289917A (ja) 1990-04-25 1990-11-29 Sony Corp 回転ヘッドドラム装置
US6033854A (en) 1991-12-16 2000-03-07 Biotronics Corporation Quantitative PCR using blocking oligonucleotides
US5837832A (en) 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
WO1995006137A1 (en) 1993-08-27 1995-03-02 Australian Red Cross Society Detection of genes
US5830645A (en) 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
US5786146A (en) 1996-06-03 1998-07-28 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
DE69733282T2 (de) 1996-06-04 2006-01-19 University Of Utah Research Foundation, Salt Lake City Überwachung der Hybridisierung während PCR
WO1998049557A1 (en) 1997-04-28 1998-11-05 B-E Safe, Inc. Taxonomic identification of microorganisms, proteins and peptides involved in vertebrate disease states
US6331393B1 (en) 1999-05-14 2001-12-18 University Of Southern California Process for high-throughput DNA methylation analysis
US6180349B1 (en) 1999-05-18 2001-01-30 The Regents Of The University Of California Quantitative PCR method to enumerate DNA copy number
DE10130800B4 (de) 2001-06-22 2005-06-23 Epigenomics Ag Verfahren zum Nachweis von Cytosin-Methylierung mit hoher Sensitivität
EP2339028A1 (en) 2001-09-14 2011-06-29 Clinical Genomics Pty. Ltd Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma
WO2004046313A2 (en) 2002-06-26 2004-06-03 Cold Spring Harbor Laboratory Methods and compositions for determining methylation profiles
JP3711984B2 (ja) 2003-02-14 2005-11-02 日産自動車株式会社 ハイブリッド車両の制御装置
JP4453297B2 (ja) 2003-05-27 2010-04-21 トヨタ自動車株式会社 車両用遊星歯車式多段変速機
US7901880B2 (en) 2003-10-21 2011-03-08 Orion Genomics Llc Differential enzymatic fragmentation
US7459274B2 (en) 2004-03-02 2008-12-02 Orion Genomics Llc Differential enzymatic fragmentation by whole genome amplification
AU2007231546B2 (en) 2006-03-28 2012-04-26 Commonwealth Scientific And Industrial Research Organisation Amplification of DNA fragments
JP2010527577A (ja) 2006-05-22 2010-08-19 クリニカル ジェノミクス ピーティーワイ リミテッド 検出方法
US20090075264A1 (en) * 2007-02-02 2009-03-19 Orion Genomics Llc Gene methylation in liver cancer diagnosis
JP2010517582A (ja) * 2007-02-12 2010-05-27 ザ・ジョンズ・ホプキンス・ユニバーシティー 結腸癌の早期検出および予後診断の方法
WO2009043112A1 (en) 2007-10-04 2009-04-09 Commonwealth Scientific And Industrial Research Organisation Nucleic acid amplification
EP2215258A4 (en) 2007-10-23 2010-12-01 Clinical Genomics Pty Ltd METHOD FOR DIAGNOSING TUMOR DISEASES
CN110079598A (zh) 2007-10-23 2019-08-02 临床基因组学有限公司 诊断新生物的方法–ii
ES2541178T3 (es) * 2009-02-03 2015-07-16 Mdxhealth Sa Método de detección de cáncer colorrectal
WO2010135786A1 (en) 2009-05-29 2010-12-02 Clinical Genomics Pty. Ltd. A method for diagnosing neoplasms and molecules for use therein
US20130059734A1 (en) 2009-11-13 2013-03-07 Commonwealth Scientific And Industrial Research Organisation Epigenetic analysis
WO2011126768A2 (en) * 2010-03-29 2011-10-13 Mayo Foundation For Medical Education And Research Methods and materials for detecting colorectal cancer and adenoma
EP2388336A1 (en) * 2010-05-19 2011-11-23 Signature Diagnostics AG Method and kits for diagnosing colorectal cancer
DK3034628T5 (en) * 2010-09-13 2019-02-18 Clinical Genomics Pty Ltd DIAGNOSTICATION OF CANCER USING METHYLATION MARKER
US10041948B2 (en) * 2010-10-12 2018-08-07 Mayo Foundation For Medical Education And Research Materials and methods for determining cancer risk
WO2012054975A1 (en) 2010-10-28 2012-05-03 Clinical Genomics Pty. Ltd. Method of microvesicle enrichment
JP2014513959A (ja) 2011-05-05 2014-06-19 クリニカル ジェノミクス ピーティーワイ リミテッド 新生物の診断方法
JP6085603B2 (ja) * 2011-08-25 2017-02-22 クリニカル ゲノミクス プロプライエタリー リミテッド 結腸直腸がん及び乳がん診断法におけるｄｎａメチル化
NZ701527A (en) * 2012-05-11 2016-07-29 Clinical Genomics Pty Ltd Diagnostic gene marker panel for colorectal cancer
DK2850212T3 (da) 2012-05-18 2020-03-23 Clinical Genomics Pty Ltd Fremgangsmåde til screening for colorektal cancer
WO2014078913A1 (en) * 2012-11-26 2014-05-30 Clinical Genomics Pty Ltd A method of detecting methylation
WO2015187823A2 (en) * 2014-06-04 2015-12-10 Quest Diagnostics Investments Incorporated Methylated markers for colorectal cancer

Also Published As

Publication number Publication date
CN104411835A (zh) 2015-03-11
CA3152533A1 (en) 2013-11-14
JP2015515862A (ja) 2015-06-04
EP2847355A4 (en) 2016-05-25
WO2013166558A8 (en) 2014-12-11
US11254985B2 (en) 2022-02-22
CA2872867A1 (en) 2013-11-14
CA3083314A1 (en) 2013-11-14
WO2013166558A1 (en) 2013-11-14
AU2019201294A1 (en) 2019-03-14
JP2020089378A (ja) 2020-06-11
US20150141275A1 (en) 2015-05-21
JP6837458B2 (ja) 2021-03-03
JP6742726B2 (ja) 2020-08-19
CA2872867C (en) 2020-09-15
BR112014028122B1 (pt) 2022-08-23
AU2013258880B2 (en) 2019-02-14
NZ701527A (en) 2016-07-29
JP6975807B2 (ja) 2021-12-01
MX368034B (es) 2019-09-17
JP2018198600A (ja) 2018-12-20
CA3083314C (en) 2023-01-31
EP4001436B1 (en) 2024-03-13
AU2021265861A1 (en) 2021-12-02
BR112014028122A2 (es) 2017-08-15
MX2014013684A (es) 2015-06-10
US20220213559A1 (en) 2022-07-07
HK1208058A1 (en) 2016-02-19
ES2749514T3 (es) 2020-03-20
DK3594366T3 (da) 2021-09-13
EP3594366B1 (en) 2021-06-23
AU2013258880A1 (en) 2014-11-20
EP3594366A1 (en) 2020-01-15
EP2847355B1 (en) 2019-07-10
CA3152533C (en) 2023-10-17
CN104411835B (zh) 2019-12-20
IL235411A0 (en) 2014-12-31
ZA201408120B (en) 2019-11-27
EP4001436A1 (en) 2022-05-25
AU2019201294B2 (en) 2021-08-19
DK2847355T3 (da) 2019-10-14
EP2847355A1 (en) 2015-03-18

Similar Documents

Publication Publication Date Title
MX2019010935A (es) Panel de marcadores geneticos para el diagnostico de cancer colorrectal.
MX2013000917A (es) Metodos para detectar las enfermedades o condiciones usando celulas fagociticas.
HK1211360A1 (en) Systems and methods relating to network-based biomarker signatures
MX2019008211A (es) Estructuras fibrosas que comprenden particulas y metodos para fabricarlas.
PH12014502704B1 (en) Compounds and compositions for modulating egfr activity
MX2016000997A (es) Metodos y composiciones para detectar contaminacion bacteriana.
MA34058B1 (fr) Formes de rifaximine, et leurs utilisations
MX2014000116A (es) Metodos y acidos nucleicos para determinar el pronostico de un sujeto con cancer.
MY157341A (en) Methods and compositions for treating lung cancer
EP2825963A4 (en) TERM INSTRUMENTS MESSAGE
EP2723866A4 (en) METHOD FOR THE PROGNOSIS AND / OR DIAGNOSIS OF NEURODEEGENERATIVE DISEASES, METHOD FOR IDENTIFYING COMPOUND CANDIDATES AND COMPOUNDS FOR THE TREATMENT OF NEURODEGENATIVE DISEASES
EP2892524A4 (en) PREVENTING THE RECHUTE OF PULMONARY CANCER WITH A LIPID / CISPLATIN COMPLEX
MX2014014464A (es) Peptidos penetrantes de celulas y metodos para identificar peptidos penetrantes de celulas.
IL236436A0 (en) Kits and methods for the detection of cyanide
EP3385717A3 (en) Methods of detecting prostate cancer
EP2967351A4 (en) Continuous optode fluorescent measurement system
HRP20200204T1 (hr) Uređaj za elektrolizu i postupak za upravljanje istim
MY168379A (en) Air conditioner
MY170453A (en) Etching material
SG11201502998UA (en) Methods and kits for increasing or predicting oil yield
WO2015066439A8 (en) Methods of treating hematological malignancies
IN2012DE00794A (es)
BR112014028357A2 (pt) célula eletrolítica para produção de metais de terras raras.
UA69321U (ru) (cS)-5,11,17,23-ТЕТРА-ТРЕТ.-БУТИЛ-27-ГИДРОКСИКАРБОНИЛМЕТОКСИ-25,28-ДИГИДРОКСИ-26-ПРОПОКСИКАЛИКС[4]АРЕН И (cR)-5,11,17,23-ТЕТРА-ТРЕТ-БУТИЛ-27-ГИДРОКСИКАРБОНИЛМЕТОКСИ-25,26-ДИГИДРОКСИ-28-ПРОПОКСИКАЛИКС[4]АРЕН
IN2013DE02963A (es)